372 related articles for article (PubMed ID: 35994720)
1. An Insight Into Pathophysiology, Epidemiology, and Management of Cardiovascular Complications of SARS-CoV-2 Infection, Post-acute COVID Syndrome, and COVID Vaccine.
Davoudi F; Miyashita S; Yoo TK; Lee PT; Foster GP
Crit Pathw Cardiol; 2022 Sep; 21(3):123-129. PubMed ID: 35994720
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and cardiovascular disease: manifestations, pathophysiology, vaccination, and long-term implication.
Abdel Moneim A; Radwan MA; Yousef AI
Curr Med Res Opin; 2022 Jul; 38(7):1071-1079. PubMed ID: 35575011
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and management of myocardial injury in coronavirus disease 2019.
Wei ZY; Geng YJ; Huang J; Qian HY
Eur J Heart Fail; 2020 Nov; 22(11):1994-2006. PubMed ID: 32683753
[TBL] [Abstract][Full Text] [Related]
4. Post-acute COVID-19 syndrome.
Nalbandian A; Sehgal K; Gupta A; Madhavan MV; McGroder C; Stevens JS; Cook JR; Nordvig AS; Shalev D; Sehrawat TS; Ahluwalia N; Bikdeli B; Dietz D; Der-Nigoghossian C; Liyanage-Don N; Rosner GF; Bernstein EJ; Mohan S; Beckley AA; Seres DS; Choueiri TK; Uriel N; Ausiello JC; Accili D; Freedberg DE; Baldwin M; Schwartz A; Brodie D; Garcia CK; Elkind MSV; Connors JM; Bilezikian JP; Landry DW; Wan EY
Nat Med; 2021 Apr; 27(4):601-615. PubMed ID: 33753937
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective.
Talasaz AH; Kakavand H; Van Tassell B; Aghakouchakzadeh M; Sadeghipour P; Dunn S; Geraiely B
Cardiovasc Drugs Ther; 2021 Apr; 35(2):249-259. PubMed ID: 32671601
[TBL] [Abstract][Full Text] [Related]
6. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
7. The Cardiovascular Manifestations of COVID-19.
Louis DW; Saad M; Vijayakumar S; Ilyas S; Kokkirala A; Aronow HD
Cardiol Clin; 2022 Aug; 40(3):277-285. PubMed ID: 35851451
[TBL] [Abstract][Full Text] [Related]
8. Adverse Cardiovascular Effects of COVID-19 Vaccination: A Systematic Review.
Huang JH; Ju KS; Liao TW; Lin YK; Yeh JS; Chen YJ
Cardiol Rev; 2024 Jul-Aug 01; 32(4):314-319. PubMed ID: 38848534
[TBL] [Abstract][Full Text] [Related]
9. Multisystem Inflammatory Syndrome in Adults After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Coronavirus Disease 2019 (COVID-19) Vaccination.
Belay ED; Godfred Cato S; Rao AK; Abrams J; Wilson WW; Lim S; Newton-Cheh C; Melgar M; DeCuir J; Webb B; Marquez P; Su JR; Meng L; Grome HN; Schlaudecker E; Talaat K; Edwards K; Barnett E; Campbell AP; Broder KR; Bamrah Morris S
Clin Infect Dis; 2022 Aug; 75(1):e741-e748. PubMed ID: 34849680
[TBL] [Abstract][Full Text] [Related]
10. Management of acute cardiovascular events in patients with COVID-19.
Liao CT; Chang WT; Yu WL; Toh HS
Rev Cardiovasc Med; 2020 Dec; 21(4):577-581. PubMed ID: 33388002
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and cardiovascular disease in patients with chronic kidney disease.
Del Vecchio L; Balafa O; Dounousi E; Ekart R; Fernandez BF; Mark PB; Sarafidis P; Valdivielso JM; Ferro CJ; Mallamaci F
Nephrol Dial Transplant; 2024 Jan; 39(2):177-189. PubMed ID: 37771078
[TBL] [Abstract][Full Text] [Related]
12. Neurological Complications of SARS-CoV-2 Infection and COVID-19 Vaccines: From Molecular Mechanisms to Clinical Manifestations.
Yepes M
Curr Drug Targets; 2022; 23(17):1620-1638. PubMed ID: 36121081
[TBL] [Abstract][Full Text] [Related]
13. COVID and Cardiovascular Disease: What We Know in 2021.
Chilazi M; Duffy EY; Thakkar A; Michos ED
Curr Atheroscler Rep; 2021 May; 23(7):37. PubMed ID: 33983522
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
15. The Cardiovascular Manifestations of COVID-19.
Louis DW; Saad M; Vijayakumar S; Ilyas S; Kokkirala A; Aronow HD
Heart Fail Clin; 2023 Apr; 19(2):153-161. PubMed ID: 36863807
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart review.
Almas T; Rehman S; Mansour E; Khedro T; Alansari A; Malik J; Alshareef N; Nagarajan VR; Al-Awaid AH; Alsufyani R; Alsufyani M; Rifai A; Alzahrani A; Nagarajan DR; Abdullatif T; Gunasaegaram V; Alzadjali E; Subramanian A; Rahman A; Sattar Y; Galo J; Virk HUH; Alraies MC
Biomed Pharmacother; 2022 May; 149():112843. PubMed ID: 35325848
[TBL] [Abstract][Full Text] [Related]
17. Cardiac Involvement of COVID-19: A Comprehensive Review.
Chang WT; Toh HS; Liao CT; Yu WL
Am J Med Sci; 2021 Jan; 361(1):14-22. PubMed ID: 33187633
[TBL] [Abstract][Full Text] [Related]
18. Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?
Chang X; Ismail NI; Rahman A; Xu D; Chan RWY; Ong SG; Ong SB
Antioxid Redox Signal; 2023 Mar; 38(7-9):599-618. PubMed ID: 36053670
[No Abstract] [Full Text] [Related]
19. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner.
Agrawal H; Das N; Nathani S; Saha S; Saini S; Kakar SS; Roy P
Stem Cell Rev Rep; 2021 Feb; 17(1):94-112. PubMed ID: 33029768
[TBL] [Abstract][Full Text] [Related]
20. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
